Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES)
Zhenguo Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Juhong Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Yimin Mao(Beijing Hospital), Kaiyuan Zhen(Xinjiang University), Sinan Wu(National Clinical Research Center for Digestive Diseases), Yingqun Ji(Dalian Medical University), Qun Yi(Sichuan University), Zhonghe Zhang(Dalian Medical University), Yuanhua Yang(Capital Medical University), Zhihong Liu(Hebei Medical University), Shuai Zhang(Binzhou Medical University), Zhu Zhang(Hong Kong Baptist University), Hong Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jie Zhang(Second Affiliated Hospital of Jilin University), Yunxia Zhang(Shanghai Jiao Tong University), Dingyi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Wan(Fudan University), Wanmu Xie(China-Japan Friendship Hospital), Xincao Tao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jieping Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaomao Xu(Beijing Hospital), Baomin Fang(Beijing Hospital)
Cited by 57
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k